Search form

 

Press Releases


Please select a year to review:
           

2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004

2007

December 20, 2007
CORRECTION FROM SOURCE: Axcan Pharma Inc. Obtains Interim Order for Proposed Arrangement and Announces Date of Special Shareholder Meeting

December 20, 2007
Axcan Pharma Inc. Obtains Interim Order for Proposed Arrangement and Announces Date of Special Shareholder Meeting

November 29, 2007
Axcan Updates on Upcoming Analyst and Investor Events

November 29, 2007
Axcan Pharma Continues its Solid Growth Trend, Closing Fiscal 2007 With Record Annual Revenue of $348.9 Million, a 19.4% Increase Over Fiscal 2006

November 29, 2007
Axcan Pharma Inc. to be Acquired by TPG Capital and Affiliates for US$1.3 Billion or US$23.35 Per Share in Cash

November 27, 2007
Axcan Pharma to Present at the BMO Capital Markets Focus on Healthcare Conference

November 26, 2007
Axcan Pharma to Host Analyst and Investor Luncheon in New York on December 6, 2007

November 19, 2007
Axcan Announces Conference Call and Webcast for Fourth Quarter and Fiscal 2007 Results

November 07, 2007
Axcan Pharma to Present at the Credit Suisse Annual Healthcare Conference

November 01, 2007
Axcan Pharma to Present at the CIBC World Markets 18th Annual Healthcare Conference

October 23, 2007
Media Advisory/REMINDER: BIOQuebec Celebrates the 25th Anniversary of Axcan Pharma

October 22, 2007
Media Advisory: BIOQuebec Celebrates the 25th Anniversary of Axcan Pharma

October 01, 2007
Axcan Licenses Rights to Cx401, an Innovative Biological Product in Development for the Treatment of Perianal Fistulas, a Significant Unmet Medical Need

September 20, 2007
Axcan Pharma to Present at the CIBC World Markets 6th Annual Eastern Institutional Investor Conference

September 19, 2007
Axcan Pharma to Present at the UBS Global Life Sciences Conference

September 14, 2007
Axcan Pharma to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London, UK

August 23, 2007
Axcan Pharma to Present at the Thomas Weisel Partners Healthcare Conference 2007

August 09, 2007
Axcan Pharma Sustains Growth in Fiscal 2007, With Record Revenue of $92.3 Million in the Third Quarter

August 02, 2007
Axcan Pharma Submits Complete New Drug Application for ULTRASE

July 30, 2007
Axcan Pharma Strengthens its Management Team with the Appointment of Nicholas Franco as Senior Vice President, International Commercial Operations

July 27, 2007
Axcan Announces Conference Call and Webcast for Third Quarter of Fiscal 2007 Results

June 29, 2007
Axcan Pharma Completes Redemption and Conversion of all $125 Million 4.25% Convertible Subordinated Notes Due 2008

June 21, 2007
Axcan Pharma Submits CMC Portion of its New Drug Application for ULTRASE and is Granted Fast Track Status

June 14, 2007
Axcan Pharma Initiates MAX-002 Phase III Clinical Trial to Evaluate the Efficacy and Safety of a High-Concentration 1 Gram Mesalamine Suppository

May 15, 2007
Axcan Pharma Calls for Redemption its US$ 125 Million 4 1/4% Convertible Subordinated Notes Due in April 2008

May 10, 2007
Axcan Pharma Intends to Redeem its US$ 125 Million 4 1/4% Convertible Subordinated Notes Due in April 2008

May 10, 2007
Axcan Pharma Continues Solid Growth in Fiscal 2007, With Record Revenue of $85.3 Million in the Second Quarter

May 09, 2007
Axcan Pharma to Present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference

May 07, 2007
Axcan Announces the U.S. Launch of PYLERA, an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori

May 02, 2007
Axcan Pharma to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference

May 01, 2007
Axcan Announces Conference Call and Webcast for Second Quarter of Fiscal 2007 Results

April 04, 2007
Axcan Pharma to Present at the CIBC World Markets Biotechnology and Specialty Pharmaceuticals Conference

March 23, 2007
Axcan Pharma to Present at the Scotia Capital Spring Growth Conference in Montreal

February 28, 2007
Axcan Pharma Outlines Growth Strategy at Annual Meeting of Shareholders

February 26, 2007
Axcan Pharma to Hold Annual General and Special Meeting of Shareholders on February 28, 2007

February 08, 2007
Strong Start for Axcan Pharma's Fiscal 2007, With Record Revenue of $78.8 Million in the First Quarter

January 31, 2007
Axcan to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference

January 30, 2007
Axcan Announces Conference Call and Webcast for First Quarter of Fiscal 2007 Results

January 04, 2007
Axcan Pharma to Present at the 25th Annual JP Morgan Healthcare Conference in San Francisco